5HT2c receptor agonists

Details 5HT2c receptor agonists 5HT2c receptor agonists

2007-04-24

2007-04-24

Tucker, Zachary C. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S346000

Reexamination Certificate

active

10876954

ABSTRACT:
The present invention provides piperazine derivatives of formula (I)as well as pharmaceutically acceptable salts and esters thereof, wherein R1to R5have the significance given in the description. They can be used for the treatment of obesity.

REFERENCES:
patent: 3317524 (1967-05-01), Freed et al.
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4776409 (1988-10-01), Manchak, Jr.
patent: 4844807 (1989-07-01), Manchak, Jr.
patent: 4844839 (1989-07-01), Manchak, Jr.
patent: 4931463 (1990-06-01), Barbier et al.
patent: 4983746 (1991-01-01), Barbier et al.
patent: 5175186 (1992-12-01), Barbier et al.
patent: 5245056 (1993-09-01), Karpf et al.
patent: 5246960 (1993-09-01), Barbier et al.
patent: 5399720 (1995-03-01), Karpf et al.
patent: 5432177 (1995-07-01), Baker et al.
patent: 6004996 (1999-12-01), Shah et al.
patent: 6365598 (2002-04-01), Adams et al.
patent: 6380238 (2002-04-01), Adams et al.
patent: 6433175 (2002-08-01), Adams et al.
patent: 6552062 (2003-04-01), Adams et al.
patent: 6610685 (2003-08-01), Bentley et al.
patent: 6706750 (2004-03-01), Bentley et al.
patent: 2002/0035110 (2002-03-01), Bentley et al.
patent: 2002/0160997 (2002-10-01), Bentley et al.
patent: 2003/0216401 (2003-11-01), Bentley et al.
patent: 2004/0039200 (2004-02-01), Adams et al.
patent: 2004/0092525 (2004-05-01), Adams et al.
patent: 185359 (1985-12-01), None
patent: 189577 (1985-12-01), None
patent: 443449 (1991-02-01), None
patent: 524495 (1992-07-01), None
patent: 0572863 (1993-12-01), None
patent: 655440 (1995-05-01), None
patent: 0 657426 (1995-06-01), None
patent: 1 132389 (2001-12-01), None
patent: WO 98/30548 (1998-07-01), None
patent: WO 99/34786 (1999-07-01), None
patent: WO 00/09122 (2000-02-01), None
patent: WO 00/09123 (2000-02-01), None
patent: WO 00/12510 (2000-03-01), None
patent: WO 200012482 (2000-03-01), None
patent: WO 200017170 (2000-03-01), None
patent: WO 0035922 (2000-06-01), None
patent: WO 00/44753 (2000-08-01), None
patent: WO 200112602 (2001-02-01), None
patent: WO 03/064423 (2003-08-01), None
J. Am. Chem. Soc (1983), 105(22), 6719.
J. Org. Chem. (1976) 14 (17), 2846.
Keller & Wahli: Trends Endocrin. Metab. (1993) 4, 291-296.
MacDonald & Lane: Current Biology, vol. 5, pp. 618-621 (1995).
Parker, “Obesity: Trends and Treatments”, Scrip Reports, PJB Publications Limited, (1996).
Kennett et al., Psychopharmacology, 96, pp. 93-100 (1988).
Kennett et al., Eur. J. Pharmacol., 141, pp. 429-435 (1987).
Kitchener et al., Psychopharmacology, 113, pp. 369-377 (1994).
Walsh et al., Psychopharmacology, 116, pp. 120-122 (1994).
Sargeant et al., Psychopharmacology, 133, pp. 309-312 (1997).
Tecott et al., Nature, vol. 374, pp. 542-546 (1995).
Kennett et al., Neuropharmacology, vol. 36, pp. 609-620 (1997).
Hoyer et al., European J. Pharmacology, 118, pp. 13-23 (1985).
Schmuck et al., FEBS Letters, 342, pp. 85-90 (1994).
McKenna et al., J. Neuroscience, 9, pp. 3482-3490 (1989).
Cheng et al., Biochem. Pharmacol., 22(23) pp. 3099-3108 (1973).
Kondo et al., J. Org. Chem., 62, pp. 6507-6511 (1997).
Mutoh et al., J. Antibiot., 47(12), pp. 1369-1375 (1994).
Abstract CA 2132887, 1995.
Abstract CA 2153937, 1996.
Kiuchi, et. al., Pub Med Abstract (Nippon Rinsho 52(5): 1190-5), May 1994.
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEd., V. 2, p. 1992-6 (1996).
Layzer, Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20thEd., V. 2, p. 2050-7 (1996).

Affiliated with

Also associated with

Rating

5HT2c receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5HT2c receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5HT2c receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3731641